SCHEMBL12401794

SCHEMBL12401794

CC(C)NC(=O)CCCCNC(=O)CCN1C(=O)C=CC1=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.43
FAAH O00519 1/20 0.43
MAPK1 P28482 1/20 0.43
KMT2A Q03164 1/20 0.43
EPHX2 P34913 1/20 0.41
PTGS1 P23219 4/20 0.41
PTGS2 P35354 4/20 0.41
HSD17B10 Q99714 2/20 0.39
POLB P06746 1/20 0.39
NAMPT P43490 1/20 0.39
HPGD P15428 2/20 0.38
KDM4E B2RXH2 2/20 0.38
OPRM1 P35372 2/20 0.38
OPRD1 P41143 2/20 0.38
OPRK1 P41145 2/20 0.38
HTT P42858 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
HDAC3 O15379 1/20 0.37
HDAC4 P56524 1/20 0.37
HDAC1 Q13547 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12412463 0.87 KDM4E (0.45) MEN1FAAHMAPK1KMT2APTGS1
SCHEMBL24358293 0.86 POLB (0.41) FAAHMAPK1PTGS1PTGS2HSD17B10
SCHEMBL17721377 0.84 PTGS1 (0.58) MEN1FAAHMAPK1KMT2APTGS1
SCHEMBL18995821 0.84 PTGS1 (0.51) FAAHMAPK1PTGS1PTGS2HPGD
SCHEMBL12659454 0.83 NAMPT (0.47) FAAHMAPK1PTGS1PTGS2NAMPT
SCHEMBL20752853 0.83 PTGS1 (0.46) FAAHMAPK1PTGS1PTGS2NAMPT
SCHEMBL21388417 0.83 PTGS1 (0.46) FAAHMAPK1PTGS1PTGS2NAMPT
SCHEMBL17175252 0.83 NAMPT (0.43) FAAHPTGS1PTGS2HSD17B10POLB
SCHEMBL253991 0.83 PTGS1 (0.51) MEN1FAAHKMT2APTGS1PTGS2
SCHEMBL14984835 0.82 PTGS1 (0.49) FAAHMAPK1PTGS1PTGS2HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110184293-A1 DEVICE, METHOD AND KIT FOR IN VIVO DETECTION OF A BIOMARKER GIVEN IMAGING LTD. (IL) 2011-07-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110184293-A1 DEVICE, METHOD AND KIT FOR IN VIVO DETECTION OF A BIOMARKER SERPINA3, SERPINA2, SERPINE1 MEN1 715/4885FAAH 873/4885MAPK1 2947/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.